🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hypofractionated Radiotherapy

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome An Evaluation of Dose-escalation for Intrathoracic Tumours NCT06794125NA4 sites📍 Kelowna📍 Saint John📍 London Chris Goodman · Tests: Hypofractionated Radiation Therapy, Radiation Therapy Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer NCT06527898Phase 1, Phase 21 site📍 Hefei Anhui Provincial Hospital · Tests: hypofractionated radiotherapy with immunotherapy Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors NCT07691619Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Postoperative hypo-fractionated radiotherapy A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. NCT06677879Phase 21 site📍 Shanghai Shanghai Proton and Heavy Ion Center · Tests: Proton radiotherapy, Photon radiotherapy Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction NCT07835139NA1 site📍 Shanghai Fudan University · Tests: ConvRT, HypoRT Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer NCT07632079Phase 27 sites📍 Amsterdam📍 Apeldoorn📍 Apeldoorn Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Hypofractionation, carboplatin + paclitaxel (CP) Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis NCT06389422Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy, Pembrolizumab Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial NCT06496256NA13 sites📍 Chandler📍 Santa Barbara📍 Boca Raton Palette Life Sciences, Inc. · Tests: Barrigel, Transrectal Ultrasound Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer NCT06641635Phase 31 site📍 Beijing Peking Union Medical College Hospital · Tests: Moderated hypofractionated online adaptive radiotherapy, Conventional radiotherapy Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI NCT06545747Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: DCE-MRI based split-course hypo-RT, CT based split-course hypo-RT, Concurrent chemotherapy, Consolidative immunotherapy Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer NCT06656598Phase 225 sites📍 Angers📍 Angers📍 Avignon Intergroupe Francophone de Cancerologie Thoracique · Tests: Carboplatin, Paclitaxel, Cemiplimab, Curative hypofractionated radiotherapy, Cemiplimab (maintenance) Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base NCT05861245NA1 site📍 Madrid Quironsalud · Tests: 5-fraction hipofractionated protontheray, 25-fraction hypofractionated proton therapy 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) NCT04610372NA4 sites📍 Kelowna📍 Surrey📍 Vancouver British Columbia Cancer Agency · Tests: Hypofractionated external beam radiotherapy, High dose rate brachytherapy, Permanent seed implant, Stereotactic body ra… Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy NCT05856773Phase 39 sites📍 Scottsdale📍 San Diego📍 Jacksonville Proton Collaborative Group · Tests: Proton Therapy A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer NCT05691010EARLY Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intensity-modulated radiation therapy, Carboplatin, Paclitaxel Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01) NCT05224934NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: ultra-hypofractionated radiotherapy Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H) NCT06461793Phase 21 site📍 Seoul Samsung Medical Center · Tests: Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer NCT06954831Phase 27 sites📍 Arcadia📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration, Radiatio… Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation NCT07615049Phase 367 sites📍 Birmingham📍 Anaheim📍 Antioch SWOG Cancer Research Network · Tests: 3-Dimensional Conformal Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Computed … Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient NCT07198217Phase 21 site📍 Zibo Zibo Municipal Hospital · Tests: SBRT combined with Tislelizumab followed by Tislelizumab A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer NCT07358676Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Bemotuzumab + Anlotinib + Chemotherapy + Radiotherapy Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma NCT04430452Phase 21 site📍 San Francisco Mary Feng, MD · Tests: Durvalumab, Hypofractionated Radiation Therapy, Tremelimumab Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes NCT06321653n/a1 site📍 Milan European Institute of Oncology · Tests: Hypofractionated radiotherapy scheme Hypofractionated Radiation Therapy for Merkel Cell Carcinoma NCT05100095Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Radiation therapy Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study NCT05857631NA2 sites📍 Navi Mumbai📍 Mumbai Tata Memorial Centre · Tests: Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin, Vaginal brachytherapy Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction NCT05491395NA1 site📍 Barretos Barretos Cancer Hospital · Tests: Hypofractionation Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer NCT07500701Phase 31 site📍 Seoul Samsung Medical Center · Tests: Moderate hypofractionated radiotherapy (Moderate-hypoRT), Ultra-hypofractionated radiotherapy (Ultra-hypoRT) Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) NCT05038332Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Ultra-hypofractionated radiation therapy, Moderately Hypo-fractionated Radiation Therapy Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer NCT06355050n/a1 site📍 Jena Jena University Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy